(Q34603754)

3 August 2017

title

Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity (English)

1 reference

3 August 2017

0 references

Yun Sok Lee

2

0 references

Jae Bum Kim

object named as

Jae Bum Kim

11

0 references

author name string

Woo Sik Kim

1

1 reference

3 August 2017

Seung Hun Cha

3

1 reference

3 August 2017

Hyun Woo Jeong

4

1 reference

3 August 2017

Sung Sik Choe

5

1 reference

3 August 2017

Mi-Ran Lee

6

1 reference

3 August 2017

Goo Taeg Oh

7

1 reference

3 August 2017

Hye-Sun Park

8

1 reference

3 August 2017

Ki-Up Lee

9

1 reference

3 August 2017

M Daniel Lane

10

1 reference

3 August 2017

publication date

27 January 2009

1 reference

American Journal of Physiology - Endocrinology and Metabolism

3 August 2017

published in

1 reference

3 August 2017

volume

296

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

E812-9

1 reference

Treatment of non-alcoholic fatty liver disease

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Liver adenosine monophosphate-activated kinase-alpha2 catalytic subunit is a key target for the control of hepatic glucose production by adiponectin and leptin but not insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Inhibition of lipid synthesis through activation of AMP kinase: an additional mechanism for the hypolipidemic effects of berberine

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

The AMP-activated protein kinase cascade--a unifying system for energy control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Inhibition of hypothalamic fatty acid synthase triggers rapid activation of fatty acid oxidation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Hypothalamic malonyl-CoA triggers mitochondrial biogenesis and oxidative gene expression in skeletal muscle: Role of PGC-1alpha.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine-stimulated glucose uptake in L6 myotubes involves both AMPK and p38 MAPK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Mice overexpressing human uncoupling protein-3 in skeletal muscle are hyperphagic and lean

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Uncoupling proteins 2 and 3 are highly active H(+) transporters and highly nucleotide sensitive when activated by coenzyme Q (ubiquinone)

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Hypothalamic malonyl-CoA as a mediator of feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine activates GLUT1-mediated glucose uptake in 3T3-L1 adipocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Abnormal lipid and glucose metabolism in obesity: implications for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Adiponectin acts in the brain to decrease body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

DHEA administration increases brown fat uncoupling protein 1 levels in obese OLETF rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Pioglitazone treatment activates AMP-activated protein kinase in rat liver and adipose tissue in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db/db mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Up-regulation of uncoupling protein 3 gene expression by fatty acids and agonists for PPARs in L6 myotubes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Metformin increases the PGC-1alpha protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Effects of chronic AICAR treatment on fiber composition, enzyme activity, UCP3, and PGC-1 in rat muscles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Effects of acute bouts of running and swimming exercise on PGC-1α protein expression in rat epitrochlearis and soleus muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Cellular distribution and developmental expression of AMP-activated protein kinase isoforms in mouse central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Induced adiposity and adipocyte hypertrophy in mice lacking the AMP-activated protein kinase-alpha2 subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Kinetic difference of berberine between hippocampus and plasma in rat after intravenous administration of Coptidis rhizoma extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Hypothalamic malonyl-coenzyme A and the control of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine improves glucose metabolism through induction of glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

AMP-activated protein kinase is required for the lipid-lowering effect of metformin in insulin-resistant human HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Role of AMP-activated protein kinase in mechanism of metformin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

Berberine stimulates glucose transport through a mechanism distinct from insulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.90710.2008

10.1152/AJPENDO.90710.2008

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference